back to Meetings page
- IMMPACT-XVII Slide Presentations
- 1. FDA recommendations for the development or selection of outcome measures
- Ashley Slagle, PhD
- 2. FDA approach to review of outcome measures for drug approval and labeling
- Elektra Papadopoulos, MD
- 3. Conceptual overview: what exactly do we mean by physical function?
- Dorcas Beaton, PhD
- 4. Patient-reported outcome measures of physical function
- Ann Taylor, PhD
- 5. Clinician, observer, laboratory, and other outcome measures of physical function
- Kristine Phillips, MD, PhD
- 6. Actigraphy
- Kushang Patel, PhD
- 7. Social participation outcome measures
- David Williams, PhD
- 8. Work participation outcome measures
- Monique Gignac, PhD
- 9. Outcome measures involving caregiver burden
- John Markman, MD
- 10. Interpreting the clinical importance of improvements in patient-reported and "objective" assessments of physical function
- Daniel Clauw, MD